cagrilintide tirzepatide combination study Efficacy and safety of once-weekly cagrilintide–semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a Semaglutide, a glucagon-like peptide-1 (GLP-1)

Metformin is typically the first-line medication for type 2 diabetes in the UK, as recommended by NICE guidelines (NG28)

Patients should never stop either medication abruptly without medical advice, as this may lead to symptom recurrence

Providers adjust treatment based on your progress and feedback, though experiences vary by provider

With aging, stress, and a fast-paced lifestyle, many people experience mood swings, anxiety, insomnia, memory decline, and brain fog from blood sugar fluctuations, inflammation, low energy, and nervous system overload

By achieving a healthier weight, you can reduce pain as well as the risk of conditions associated with obesity, such as type 2 diabetes, cardiovascular disease, and hypertension

You can cancel your Maves plan at any time through your online patient portal